menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • Datafeature
  • [email protected]
  • +1 718 618 4351 (International)
  • +91 78878 22626 (Asia)

More Results

menu One Stop Shop For Reports One Stop Shop For Reports
search more_vert
  • All Reports
  • All Sectors
  • Report Library
  • Who Trust Us
  • Datafeature
Home ➤ Life Science ➤ Medical Devices & Supplies ➤ Sinus Dilation Devices Market
Sinus Dilation Devices Market

Sinus Dilation Devices Market

Published date: Nov 2023 • Formats:
Request Sample Buy Now
  • Home ➤ Life Science ➤ Medical Devices & Supplies ➤ Sinus Dilation Devices Market

Global Sinus Dilation Devices Market By Type (Balloon Sinus Dilation, and No-Balloon Sinus Dilation), By Application (Physicians Office, and Operating Room), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2023–2033

  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Sample
  • account_circleAbout Me

    Quick Navigation

    • 1 Report Overview
    • 2 Global Sinus Dilation Device Market Scope:
      • 2.1 Product Analysis
      • 2.2 Procedure Analysis
      • 2.3 End Use Analysis
      • 2.4 Application Analysis
    • 3 Key Market Segments:
    • 4 Market Dynamics
    • 5 Regional Analysis
      • 5.1 Key Regions and Countries Covered іn This Rероrt:
    • 6 Market Share Analysis
      • 6.1 Key Market Players

    Report Overview

    The Global sinus dilation device market Market size is expected to be worth around USD 6.96 billion by 2032 from USD 3 billion in 2023, growing at a CAGR of 10.60% during the forecast period from 2023 to 2032.

    The market’s growth has been fueled by the increasing popularity of minimally invasive procedures, greater awareness about the pros and cons of balloon sinuplasty, favorable reimbursement situations, as well as chronic sinusitis.

     

    Global Sinus Dilation Device Market Scope:

    Product Analysis

    In terms of ‘Product’, the largest revenue share of more than 46.3%, was accounted for by the ‘Balloon Sinus Dilation Devices’ segment in 2021. BSDs are small, flexible, safe, and highly effective in relieving sinusitis symptoms. Sinus dilation is a non-invasive procedure that does not require tissue ablation. This market for sinus Dilation Devices reports allows for quick turnaround and improved patient comfort. BSD procedures may need to be repeated as they are temporary.

    The ‘Functional Endoscopic Sinus Surgery Instruments Set’ segment is projected to experience the fastest annual growth rate, at more than 13.6%, over the forecast period. It’s used to treat chronic and recurrent acute rhino sinusitis, as well as medically refractory persistent rhino sinusitis. It is minimally invasive, and it is preferred over other procedures. This market scenario is expected to boost segment growth in the foreseeable future.

    Procedure Analysis

    With respect to ‘Procedure’, the ‘Standalone Procedure’ segment accounted for the highest revenue share, at 67.3%, in 2021. Balloon sinus ostial dilation can be done as a stand-alone procedure. A standalone balloon dilation procedure is just as effective for chronic rhino sinusitis treatment as functional endoscopic surgery. This Sinus Dilation Devices market’s major share segment is also expected to expand owing to the increasing preference for minimally invasive procedures as a result of greater use and their acceptance by healthcare insurance.

    Balloon Sinus Ostial Dilation can be performed with functional sinus surgery. This procedure is known as a “hybrid” because it combines elements of both balloon and functional sinus surgery. A hybrid functional endoscopic balloon dilation procedure for pediatric and adult patients is possible. This market trend is expected to grow due to the increasing popularity of hybrid procedures for both children and adults.

    End Use Analysis

    On the basis of ‘End-Use’, the ‘Hospitals’ segment accounted for the highest revenue market opportunity at over 50.2% in 2021. It is expected that hospitals will register substantial growth over the forecast period due to the high number of procedures being performed in hospitals. Segment growth will be bolstered by the increasing prevalence of chronic sinusitis and favorable reimbursement criteria. Segment growth will also be complemented by improved infrastructure and medical equipment, as well as a greater ability to perform complex sinus surgeries.

    The fastest CAGR is expected to be indexed by the ‘Ambulatory Surgical Centers’ segment over the forecast period. ASCs are a strategic option for providing surgical services. ASCs allow for minimally invasive procedures like BSD. This segment’s growth is expected to be driven by cost-effectiveness, as well as better reimbursement options than hospitals.

    Application Analysis

    Owing to the high prevalence of sinusitis among adults, the ‘Adult Patient’ segment accounted for 67.4% of total revenues in 2021. For instance, in September 2017, sinusitis was found to be more prevalent in adults than in children according to the CDC. In the United States, 9 out of 10 sinusitis cases were caused by viral sinusitis reported in adults.

    The ‘Pediatric’ segment is expected to index the highest CAGR over the forecast period. The rise in sinusitis among children can be attributed to this growth. According to the National Center for Biotechnology Information in the U.S. in 2015, 6-13% of children in the country developed chronic rhino sinusitis. Several key market players have begun to develop key product segments for pediatric patients in an effort to retain their respective market position.

    Key Market Segments:

    Product

    • Balloon Sinus Dilation Devices
    • Functional Endoscopic Sinus Surgery (FESS) Instruments Set
    • Endoscopes
    • Sinus Stents/Implants
    • Others

    Procedure

    • Hybrid
    • Standalone

    Application

    • Pediatric
    • Adult

    End-use

    • Hospitals
    • Ambulatory Surgical Centers (ASCs)
    • ENT Clinics/In-office

    Market Dynamics

    Market dynamics are expected to be boosted by the development of new techniques for surgery, which are replacing older procedures. In sinus surgery, technological advancements such as laser technologies ensure minimal ablation with fewer side effects. These procedures can now be performed as outpatient treatment.

    Interruptions in routine patient services were caused by the onset of the COVID-19 pandemic. Many governments on healthcare organization providers have stopped routine clinic visits and elective procedures to increase and preserve the availability of in-patient beds. In addition, they have reorganized medical staff and nursing staff. Patients with chronic rhinitis are particularly affected by this market research study. Patients opted for teleconsultations, and temporarily for sinus-related disorders.

    COVID-19 vaccines will normalize elective surgery, which is good news for this market size. Major players in this market for sinus Dilation devices report include Smith & Nephew, Smith & Nephew, Medtronic, as well as Acclarent Inc. These key players are focusing their efforts on mergers & acquisitions, as well as higher investments towards the development of technological advancements and R&D initiatives to expand their geographical reach. Smith & Nephew spent US$222 million in FY2015, and US$223 million in 2017 on research & development.

    Regional Analysis

    North America accounted for the largest market share, at 38.8% in 2021. This dominance is expected to continue over the forecast period. This market research study is due to the country’s highly regulated and well-developed healthcare infrastructure. Demand for Sinus Dilation Devices Market growth is being driven by the availability and quality of innovative product types, which is made possible by major factor market players. The Asia Pacific is expected to index the fastest annual growth rate over the forecast period, due to an increase in disposable incomes as well as greater patient awareness concerning sinus surgery.

    Olympus Corporation and InnAccel Technologies are looking to make acquisitions and expand their product approval range in order to deliver high-quality products in emerging markets for Sinus Dilation Devices. Olympus Corp. signed a definitive contract for US$ 87 million in April 2017 to acquire Image Stream Medical Inc. to provide better medical solution assistance to healthcare spending facilities.

    Key Regions and Countries Covered іn This Rероrt:

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Russia
      • Spain
      • Rest of Europe
    • APAC
      • China
      • Japan
      • South Korea
      • India
      • Rest of Asia-Pacific
    • South America
      • Brazil
      • Argentina
      • Rest of South America
    • MEA
      • GCC
      • South Africa
      • Israel
      • Rest of MEA

    Market Share Analysis

    This market growth is highly concentrated with a small number of established key companies controlling the majority stake. key market players have employed a number of key factors and business strategies to maintain their respective market major share while expanding their geographic reach. These market reports include product type launches, advanced product approvals, as well as strategic acquisitions and innovations. Stryker Corp. bought Entellus Medical, a U.S. company that provides minimally invasive ENT services in the U.S., in December 2017.

    To cater to the growing need for minimally invasive ENT procedures, Entellus Medical has introduced the Latera Absorbable Nasal Implant, MiniFESS Surgical Tools, XprESS ENT Dissection System, and FocESS Imaging & Navigation Devices.

    Key Market Players

    Market major companies in the global sinus dilation device industry include:

    • Smith & Nephew
    • Stryker
    • Medtronic
    • Olympus Corporation
    • Acclarent
    • Entellus Medical
    • SinuSys Corporation
    • Intersect ENT Inc.
    • Olympus Corporation
    • Other Key Players

    For the Sinus Dilation Devices Market research study, the following years have been considered to estimate the market size:

    Attribute Report Details

    Market Size in 2022

    USD 6.96 bn

    Growth Rate

    USD 3 bn

    Forecast Value in 2032

    10.60%

    Historical Years

    2016-2020

    Base Year

    2021

    Estimated Year

    2022

    Short Term Projection Year

    2028

    Projected Year

    2023

    Long Term Projection Year

    2032

    Report Coverage

    Competitive Landscape, Revenue analysis, Company Share Analysis, Manufacturers Analysis, Volume by Manufacturers, Key Segments, Key company analysis, Market Trends, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis, strategy for existing players to grab maximum market share, and more.

    Regional Scope

    North America, Europe, Asia-Pacific, South America, Middle East & Africa

    Country Scope

    United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa

    Frequently Asked Questions (FAQ)

    What is the sinus dilation device market growth?

    The global sinus dilation device market is expected to grow at a compound annual growth rate of 10.60% from 2023 to 2032 to reach USD 6.96 billion by 2032.

    What is the market value of Sinus Dilation Devices Market in 2023?

    The market value of Sinus Dilation Devices in 2023 was 3 billion in 2023

    Sinus Dilation Devices Market
    Sinus Dilation Devices Market
    Published date: Nov 2023 • Formats:
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
  • account_circleAbout Me
  • ondemand_videoVideos
    • Smith & Nephew
    • Stryker Corporation Company Profile
    • Medtronic
    • Olympus Corporation
    • Acclarent
    • Entellus Medical
    • SinuSys Corporation
    • Intersect ENT Inc.
    • Other Key Players
    • Nestlé S.A Company Profile
  • settingsSettings

Our Clients

  • Our Clients

Inquiry Before Buying


Sinus Dilation Devices Market
  • 18871
  • Nov 2023
    • ★★★★★
      ★★★★★
    • (74)
  • US $5,999
    US $4,499
  • US $7,999
    US $4,999
  • US $9,999
    US $5,499
Buy Now
✖

Request a Sample Report

We'll get back to you as quickly as possible

Single User
$5,999
$4,499
USD / per unit
save 25%
Multi User
$7,999
$4,999
USD / per unit
save 38%
Corporate User
$9,999
$5,499
USD / per unit
save 45%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 618 4351 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo

Find Help

  • Contact Us
  • How to Order

Legal

  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions

Explore

  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
  • Report Library

Secured Payment Options

Secured Payment Options

© 2023 Market.Us. All Rights Reserved.